Search Results - Arndt Vogel
- Showing 1 - 4 results of 4
-
1
Role of immune checkpoint inhibitor combinations in resectable and unresectable, embolization-eligible hepatocellular carcinoma by Brandon M. Meyers, Howard J. Lim, Mayur Brahmania, Dave M. Liu, Vincent C. Tam, Deanna McLeod, Ravi Ramjeesingh, Jennifer J. Knox, Arndt Vogel
Published 2025-07-01
Article -
2
Evolutionary dynamics of recurrent hepatocellular carcinoma under divergent immune selection pressures by Ankur Chakravarthy, Elisa Pasini, Xun Zhao, Jeffrey To, Shu Yi (Roxana) Shen, Sandra Fischer, Anand Ghanekar, Arndt Vogel, Robert C. Grant, Jennifer Knox, Gonzalo Sapisochin, Gregory J. Gores, Daniel De Carvalho, Daniel De Carvalho, Mamatha Bhat, Mamatha Bhat, Mamatha Bhat, Mamatha Bhat
Published 2025-08-01
Article -
3
Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence by Giulia Francesca Manfredi, Claudia Angela Maria Fulgenzi, Ciro Celsa, Bernardo Stefanini, Antonio D'Alessio, Matthias Pinter, Bernhard Scheiner, Nichola Awosika, Leonardo Brunetti, Pasquale Lombardi, Charles Latchford, Pei-Chang Lee, Yi-Hsiang Huang, Chun-Yen Lin, Andrea Dalbeni, Arndt Vogel, Peter R. Galle, Masatoshi Kudo, Lorenza Rimassa, Hong Jae Chon, Giuseppe Cabibbo, Fabio Piscaglia, Calogero Cammà, Anjana Pillai, Mario Pirisi, Amit G. Singal, David J. Pinato
Published 2025-08-01
Article -
4
SBRT for bridging and downstaging HCC before transplant by Zhihao Li, Michael Yan, Marco P.A.W. Claasen, Luckshi Rajendran, Christian T.J. Magyar, Saheli Saha, Cameron Lee, Nazia Selzner, Elmar Jaeckel, Anand Ghanekar, Mark Cattral, Blayne A. Sayed, Markus Selzner, Ian McGilvray, Chaya Shwaartz, Trevor Reichman, Grainne M. O’Kane, Arndt Vogel, Robert C. Grant, Tae Kyoung Kim, Catherine Soo-Yee Naidoo, Ali Hosni, Rebecca Wong, Aruz Mesci, Jelena Lukovic, Aisling Barry, John Kim, Laura A. Dawson, Gonzalo Sapisochin
Published 2025-08-01
Article